Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer.

Mell LK, Shen H, Nguyen-Tân PF, Rosenthal DI, Zakeri K, Vitzthum LK, Frank SJ, Schiff PB, Trotti AM 3rd, Bonner JA, Jones CU, Yom SS, Thorstad WL, Wong SJ, Shenouda G, Ridge JA, Zhang QE, Le QT.

Clin Cancer Res. 2019 Dec 1;25(23):7078-7088. doi: 10.1158/1078-0432.CCR-19-1832. Epub 2019 Aug 16.

PMID:
31420360
2.

Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.

Gabani P, Lin AJ, Barnes J, Oppelt P, Adkins DR, Rich JT, Zevallos JP, Daly MD, Gay HA, Thorstad WL.

Radiother Oncol. 2019 May;134:81-88. doi: 10.1016/j.radonc.2019.01.016. Epub 2019 Feb 4.

PMID:
31005228
3.

Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.

Fakhry C, Zhang Q, Gillison ML, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Yom SS, Wong SJ, Ridge JA, Rao SSD, Spencer S, Fortin A, Raben D, Harris J, Le QT.

Cancer. 2019 Jun 15;125(12):2027-2038. doi: 10.1002/cncr.32025. Epub 2019 Mar 26.

PMID:
30913305
4.

In Regard to Bossi et al.

Fakhry C, Nguyen-Tân PF, Lambert L, Rosenthal DI, Weber RS, Gillison ML, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):669-670. doi: 10.1016/j.ijrobp.2018.06.020. No abstract available.

PMID:
30238902
5.

Predictors of acute throat or esophageal patient reported pain during radiation therapy for head and neck cancer.

Gay HA, Oh JH, Apte AP, Daly MD, Adkins DR, Rich J, Oppelt PJ, Dyk PT, Mullen DF, Eschen L, Chin RI, Nussenbaum B, Haughey BH, Thorstad WL, Deasy JO.

Clin Transl Radiat Oncol. 2018 Sep 4;13:1-6. doi: 10.1016/j.ctro.2018.08.004. eCollection 2018 Nov.

6.

Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging.

Floberg JM, DeWees TA, Chin RI, Garsa AA, Dehdashti F, Nussenbaum B, Oppelt PJ, Adkins DR, Gay HA, Thorstad WL.

Head Neck. 2018 Oct;40(10):2280-2287. doi: 10.1002/hed.25337. Epub 2018 Jul 26.

PMID:
30051553
7.

Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care.

Gabani P, Barnes J, Lin AJ, Rudra S, Oppelt P, Adkins D, Rich JT, Zevallos JP, Daly MD, Gay HA, Thorstad WL.

Cancer Med. 2018 Aug;7(8):3592-3603. doi: 10.1002/cam4.1626. Epub 2018 Jul 14.

8.

Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil.

Chin RI, Rao YJ, Hwang MY, Spencer CR, Pierro M, DeWees T, Patel P, Sinha P, Gay HA, Daly M, Haughey BH, Nussenbaum B, Adkins DR, Lewis JS Jr, Thorstad WL.

Cancer. 2017 Dec 1;123(23):4594-4607. doi: 10.1002/cncr.30931. Epub 2017 Sep 7.

9.

Trials in head and neck oncology: Evolution of perioperative adjuvant therapy.

Zenga J, Pipkorn P, Adkins DR, Thorstad WL, Nussenbaum B.

Oral Oncol. 2017 Sep;72:80-89. doi: 10.1016/j.oraloncology.2017.07.012. Epub 2017 Jul 15. Review. No abstract available.

PMID:
28797466
10.

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.

Fakhry C, Zhang Q, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML.

J Clin Oncol. 2017 Dec 20;35(36):4057-4065. doi: 10.1200/JCO.2016.72.0748. Epub 2017 Aug 4.

11.

Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics.

Folkert MR, Setton J, Apte AP, Grkovski M, Young RJ, Schöder H, Thorstad WL, Lee NY, Deasy JO, Oh JH.

Phys Med Biol. 2017 Jul 7;62(13):5327-5343. doi: 10.1088/1361-6560/aa73cc. Epub 2017 Jun 12.

12.

Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.

Zenga J, Haughey BH, Jackson RS, Adkins DR, Aranake-Chrisinger J, Bhatt N, Gay HA, Kallogjeri D, Martin EJ, Moore EJ, Paniello RC, Rich JT, Thorstad WL, Nussenbaum B.

Laryngoscope. 2017 Sep;127(9):2033-2037. doi: 10.1002/lary.26455. Epub 2016 Dec 23.

PMID:
28008626
13.

Reevaluation of postoperative radiation dose in the management of human papillomavirus-positive oropharyngeal cancer.

Chin RI, Spencer CR, DeWees T, Hwang MY, Patel P, Sinha P, Gay HA, Haughey BH, Nussenbaum B, Adkins DR, Lewis JS Jr, Thorstad WL.

Head Neck. 2016 Nov;38(11):1643-1649. doi: 10.1002/hed.24486. Epub 2016 May 6.

PMID:
27152851
14.

Does elimination of planned postoperative radiation to the primary bed in p16-positive, transorally-resected oropharyngeal carcinoma associate with poorer outcomes?

Sinha P, Pipkorn P, Thorstad WL, Gay HA, Haughey BH.

Oral Oncol. 2016 Oct;61:127-34. doi: 10.1016/j.oraloncology.2016.08.013. Epub 2016 Sep 10.

PMID:
27688115
15.

Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.

Zenga J, Jackson RS, Graboyes EM, Sinha P, Lindberg M, Martin EJ, Ma D, Thorstad WL, Rich JT, Moore EJ, Haughey BH.

Laryngoscope. 2017 Mar;127(3):623-630. doi: 10.1002/lary.26272. Epub 2016 Sep 16.

PMID:
27634021
16.

A comparative study based on image quality and clinical task performance for CT reconstruction algorithms in radiotherapy.

Li H, Dolly S, Chen HC, Anastasio MA, Low DA, Li HH, Michalski JM, Thorstad WL, Gay H, Mutic S.

J Appl Clin Med Phys. 2016 Jul 8;17(4):377-390. doi: 10.1120/jacmp.v17i4.5763.

17.

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).

Divi V, Harris J, Harari PM, Cooper JS, McHugh J, Bell D, Sturgis EM, Cmelak AJ, Suntharalingam M, Raben D, Kim H, Spencer SA, Laramore GE, Trotti A, Foote RL, Schultz C, Thorstad WL, Zhang QE, Le QT, Holsinger FC.

Cancer. 2016 Nov 15;122(22):3464-3471. doi: 10.1002/cncr.30204. Epub 2016 Jul 15.

18.

Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Berg D, Bowen GM, Cheney RT, Daniels GA, Glass LF, Grekin RC, Grossman K, Higgins SA, Ho AL, Lewis KD, Lydiatt DD, Nehal KS, Nghiem P, Olsen EA, Schmults CD, Sekulic A, Shaha AR, Thorstad WL, Tuli M, Urist MM, Wang TS, Wong SL, Zic JA, Hoffmann KG, Engh A.

J Natl Compr Canc Netw. 2016 May;14(5):574-97.

PMID:
27160235
19.

Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.

Wong N, Khwaja SS, Baker CM, Gay HA, Thorstad WL, Daly MD, Lewis JS Jr, Wang X.

Cancer Med. 2016 Jul;5(7):1619-28. doi: 10.1002/cam4.718. Epub 2016 Apr 25.

20.

Definitive Surgical Therapy after Open Neck Biopsy for HPV-Related Oropharyngeal Cancer.

Zenga J, Graboyes EM, Haughey BH, Paniello RC, Mehrad M, Lewis JS Jr, Thorstad WL, Nussenbaum B, Rich JT.

Otolaryngol Head Neck Surg. 2016 Apr;154(4):657-66. doi: 10.1177/0194599815627642. Epub 2016 Feb 9.

PMID:
26861231
21.

A framework for automated contour quality assurance in radiation therapy including adaptive techniques.

Altman MB, Kavanaugh JA, Wooten HO, Green OL, DeWees TA, Gay H, Thorstad WL, Li H, Mutic S.

Phys Med Biol. 2015 Jul 7;60(13):5199-209. doi: 10.1088/0031-9155/60/13/5199. Epub 2015 Jun 17.

PMID:
26083863
22.

Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.

Zenga J, Wilson M, Adkins DR, Gay HA, Haughey BH, Kallogjeri D, Michel LS, Paniello RC, Rich JT, Thorstad WL, Nussenbaum B.

JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1118-27. doi: 10.1001/jamaoto.2015.0764.

PMID:
25902372
23.

High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer.

Sinha P, Kallogjeri D, Gay H, Thorstad WL, Lewis JS Jr, Chernock R, Nussenbaum B, Haughey BH.

Oral Oncol. 2015 May;51(5):514-20. doi: 10.1016/j.oraloncology.2015.02.098. Epub 2015 Mar 12.

PMID:
25771076
24.

Automated contouring error detection based on supervised geometric attribute distribution models for radiation therapy: a general strategy.

Chen HC, Tan J, Dolly S, Kavanaugh J, Anastasio MA, Low DA, Li HH, Altman M, Gay H, Thorstad WL, Mutic S, Li H.

Med Phys. 2015 Feb;42(2):1048-59. doi: 10.1118/1.4906197.

PMID:
25652517
25.

Pre-radiotherapy feeding tube identifies a poor prognostic subset of postoperative p16 positive oropharyngeal carcinoma patients.

Verma V, Liu J, Eschen L, Danieley J, Spencer C, Lewis JS Jr, Diaz J, Piccirillo JF, Adkins DR, Nussenbaum B, Thorstad WL, Gay HA.

Radiat Oncol. 2015 Jan 9;10:8. doi: 10.1186/s13014-014-0314-3.

26.

PET-based radiation therapy planning.

Speirs CK, Grigsby PW, Huang J, Thorstad WL, Parikh PJ, Robinson CG, Bradley JD.

PET Clin. 2015 Jan;10(1):27-44. doi: 10.1016/j.cpet.2014.09.003. Epub 2014 Nov 22. Review.

PMID:
25455878
27.

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, Beitler JJ, Garden AS, Spanos WJ, Yom SS, Axelrod RS.

J Clin Oncol. 2014 Sep 20;32(27):2940-50.

28.

Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.

Spencer CR, Gay HA, Haughey BH, Nussenbaum B, Adkins DR, Wildes TM, DeWees TA, Lewis JS Jr, Thorstad WL.

Cancer. 2014 Dec 15;120(24):3994-4002. doi: 10.1002/cncr.28938. Epub 2014 Aug 20.

29.

Management of human papillomavirus-related unknown primaries of the head and neck with a transoral surgical approach.

Graboyes EM, Sinha P, Thorstad WL, Rich JT, Haughey BH.

Head Neck. 2015 Nov;37(11):1603-11. doi: 10.1002/hed.23800. Epub 2014 Aug 26.

PMID:
24931847
30.

Dermatofibrosarcoma protuberans, version 1.2014.

Bichakjian CK, Olencki T, Alam M, Andersen JS, Berg D, Bowen GM, Cheney RT, Daniels GA, Glass LF, Grekin RC, Grossman K, Ho AL, Lewis KD, Lydiatt DD, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Perlis CS, Shaha AR, Thorstad WL, Tuli M, Urist MM, Wang TS, Werchniak AE, Wong SL, Zic JA, McMillian N, Hoffman K, Ho M.

J Natl Compr Canc Netw. 2014 Jun;12(6):863-8.

PMID:
24925197
31.

Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.

Cai C, Chernock RD, Pittman ME, El-Mofty SK, Thorstad WL, Lewis JS Jr.

Am J Surg Pathol. 2014 Jun;38(6):809-15. doi: 10.1097/PAS.0000000000000183.

PMID:
24698966
32.

Merkel cell carcinoma, version 1.2014.

Bichakjian CK, Olencki T, Alam M, Andersen JS, Berg D, Bowen GM, Cheney RT, Daniels GA, Glass LF, Grekin RC, Grossman K, Ho AL, Lewis KD, Lydiatt DD, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Perlis CS, Shaha AR, Thorstad WL, Tuli M, Urist MM, Wang TS, Werchniak AE, Wong SL, Zic JA, Hoffmann KG, McMillian NR, Ho M; National comprehensive cancer network.

J Natl Compr Canc Netw. 2014 Mar 1;12(3):410-24.

PMID:
24616545
33.

Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma.

Garsa AA, Chang AJ, Dewees T, Spencer CR, Adkins DR, Dehdashti F, Gay HA, Thorstad WL.

J Radiat Oncol. 2013 Mar;2(1):27-34.

34.

Extensive HPV-related carcinoma in situ of the upper aerodigestive tract with 'nonkeratinizing' histologic features.

Chernock RD, Nussenbaum B, Thorstad WL, Luo Y, Ma XJ, El-Mofty SK, Lewis JS Jr.

Head Neck Pathol. 2014;8(3):322-8. doi: 10.1007/s12105-013-0499-z. Epub 2013 Oct 23.

35.

A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinoma.

Lewis JS Jr, Ali S, Luo J, Thorstad WL, Madabhushi A.

Am J Surg Pathol. 2014 Jan;38(1):128-37. doi: 10.1097/PAS.0000000000000086.

36.

Cyclin D1-a prognostic marker in oropharyngeal squamous cell carcinoma that is tightly associated with high-risk human papillomavirus status.

Scantlebury JB, Luo J, Thorstad WL, El-Mofty SK, Lewis JS Jr.

Hum Pathol. 2013 Aug;44(8):1672-80. doi: 10.1016/j.humpath.2013.01.021. Epub 2013 Apr 6.

37.

Predicting dose-volume histograms for organs-at-risk in IMRT planning.

Appenzoller LM, Michalski JM, Thorstad WL, Mutic S, Moore KL.

Med Phys. 2012 Dec;39(12):7446-61. doi: 10.1118/1.4761864.

PMID:
23231294
38.

B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinoma.

Ukpo OC, Thorstad WL, Lewis JS Jr.

Head Neck Pathol. 2013 Jun;7(2):113-21. doi: 10.1007/s12105-012-0406-z. Epub 2012 Nov 20.

39.

Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx.

Chernock RD, Wang X, Gao G, Lewis JS Jr, Zhang Q, Thorstad WL, El-Mofty SK.

Mod Pathol. 2013 Feb;26(2):223-31. doi: 10.1038/modpathol.2012.159. Epub 2012 Sep 21.

40.

A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis.

Gao G, Chernock RD, Gay HA, Thorstad WL, Zhang TR, Wang H, Ma XJ, Luo Y, Lewis JS Jr, Wang X.

Int J Cancer. 2013 Feb 15;132(4):882-90. doi: 10.1002/ijc.27739. Epub 2012 Sep 7.

41.

Radiotherapeutic management of cervical lymph node metastases from an unknown primary site.

Perkins SM, Spencer CR, Chernock RD, Haughey BH, Nussenbaum B, Adkins DR, Kuperman DI, Thorstad WL.

Arch Otolaryngol Head Neck Surg. 2012 Jul;138(7):656-61. doi: 10.1001/archoto.2012.1110.

PMID:
22801890
42.
43.

A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma.

Gao G, Gay HA, Chernock RD, Zhang TR, Luo J, Thorstad WL, Lewis JS Jr, Wang X.

Cancer. 2013 Jan 1;119(1):72-80. doi: 10.1002/cncr.27696. Epub 2012 Jun 26.

44.

Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas--a tissue microarray study utilizing E6/E7 mRNA in situ hybridization.

Lewis JS Jr, Ukpo OC, Ma XJ, Flanagan JJ, Luo Y, Thorstad WL, Chernock RD.

Histopathology. 2012 May;60(6):982-91. doi: 10.1111/j.1365-2559.2011.04169.x. Epub 2012 Feb 23.

PMID:
22360821
45.

Lack of association of cadherin expression and histopathologic type, metastasis, or patient outcome in oropharyngeal squamous cell carcinoma: a tissue microarray study.

Ukpo OC, Thorstad WL, Zhang Q, Lewis JS Jr.

Head Neck Pathol. 2012 Mar;6(1):38-47. doi: 10.1007/s12105-011-0306-7. Epub 2011 Nov 10.

46.

Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy.

Platek ME, Reid ME, Wilding GE, Jaggernauth W, Rigual NR, Hicks WL Jr, Popat SR, Warren GW, Sullivan M, Thorstad WL, Khan MK, Loree TR, Singh AK.

Head Neck. 2011 Nov;33(11):1561-8. doi: 10.1002/hed.21640. Epub 2010 Dec 15.

47.

High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.

Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr.

Am J Surg Pathol. 2011 Sep;35(9):1343-50. doi: 10.1097/PAS.0b013e318220e59d.

PMID:
21836494
48.

Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma.

Lewis JS Jr, Carpenter DH, Thorstad WL, Zhang Q, Haughey BH.

Mod Pathol. 2011 Nov;24(11):1413-20. doi: 10.1038/modpathol.2011.105. Epub 2011 Jun 24.

49.

Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans.

Chernock RD, Zhang Q, El-Mofty SK, Thorstad WL, Lewis JS Jr.

Arch Otolaryngol Head Neck Surg. 2011 Feb;137(2):163-9. doi: 10.1001/archoto.2010.246.

50.

HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome.

Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis JS Jr.

Head Neck Pathol. 2009 Sep;3(3):186-94. doi: 10.1007/s12105-009-0126-1. Epub 2009 Jul 11.

Supplemental Content

Loading ...
Support Center